WO2008037568A3 - Reversible terminators for efficient sequencing by synthesis - Google Patents

Reversible terminators for efficient sequencing by synthesis Download PDF

Info

Publication number
WO2008037568A3
WO2008037568A3 PCT/EP2007/059207 EP2007059207W WO2008037568A3 WO 2008037568 A3 WO2008037568 A3 WO 2008037568A3 EP 2007059207 W EP2007059207 W EP 2007059207W WO 2008037568 A3 WO2008037568 A3 WO 2008037568A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydrogen
group
compounds
detectable group
detectable
Prior art date
Application number
PCT/EP2007/059207
Other languages
French (fr)
Other versions
WO2008037568A2 (en
Inventor
Diana Katerina Knapp
Joachim W Engels
Angelica Keller
Yangzhou Li
Julius Gagilas
Saulius Serva
Alina Stura
Andras Foldesi
Nilsson Camilla Estmer
Marek Kwiatkowski
Original Assignee
Quiatech Ab
Diana Katerina Knapp
Joachim W Engels
Angelica Keller
Yangzhou Li
Julius Gagilas
Saulius Serva
Alina Stura
Andras Foldesi
Nilsson Camilla Estmer
Marek Kwiatkowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quiatech Ab, Diana Katerina Knapp, Joachim W Engels, Angelica Keller, Yangzhou Li, Julius Gagilas, Saulius Serva, Alina Stura, Andras Foldesi, Nilsson Camilla Estmer, Marek Kwiatkowski filed Critical Quiatech Ab
Publication of WO2008037568A2 publication Critical patent/WO2008037568A2/en
Publication of WO2008037568A3 publication Critical patent/WO2008037568A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Abstract

The invention relates to compounds of general structure (I) or salts thereof, wherein B is a nucleobase, X and Y independently are oxygen or sulphur, Z is a chemical group characterized by strong electron withdrawing properties, R1 is hydrogen, hydroxyl or a protected hydroxyl, R2 and R3 are together or separately hydrogen or a hydrocarbyl, R4 is hydrogen or a chemical moiety consisting of a linker molecule L, linking a detectable group to the rest of the structure (I), R5 is hydrogen or an additional electron withdrawing group. R5 can be identical with Z or different. R6 is hydrogen or a chemical moiety consisting of a linker unit L, a cleavable group and a detectable group joined together in the following order R6 = -L-cleavable group-detectable group. The detectable group is placed either on R4 or R6 or is absent, thus either R4 is hydrogen and the detectable group is placed on R6, or R6 is hydrogen and the detectable group is placed on R4, or both R4 and R6 are hydrogen. Numbers m and n are independently 0 or 1. Compounds of formula (I) are useful as reversible chain extension terminators. The invention also relates to the use of the compounds (I) in nucleic acid sequencing as well as to a method of preparing compounds of Formula (I).
PCT/EP2007/059207 2006-09-04 2007-09-04 Reversible terminators for efficient sequencing by synthesis WO2008037568A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82445306P 2006-09-04 2006-09-04
US60/824,453 2006-09-04

Publications (2)

Publication Number Publication Date
WO2008037568A2 WO2008037568A2 (en) 2008-04-03
WO2008037568A3 true WO2008037568A3 (en) 2008-10-02

Family

ID=39230564

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/059207 WO2008037568A2 (en) 2006-09-04 2007-09-04 Reversible terminators for efficient sequencing by synthesis

Country Status (1)

Country Link
WO (1) WO2008037568A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2294076B1 (en) 2008-05-27 2017-03-08 TriLink BioTechnologies Chemically modified nucleoside 5'-triphosphates for thermally initiated replication of nucleic acid
US9150896B2 (en) 2012-09-06 2015-10-06 Illumina, Inc. Nucleotides and primers with removable blocking groups
US9146248B2 (en) 2013-03-14 2015-09-29 Intelligent Bio-Systems, Inc. Apparatus and methods for purging flow cells in nucleic acid sequencing instruments
US9591268B2 (en) 2013-03-15 2017-03-07 Qiagen Waltham, Inc. Flow cell alignment methods and systems
US10059929B2 (en) 2014-10-20 2018-08-28 Molecular Assemblies, Inc. Modified template-independent enzymes for polydeoxynucleotide synthesis
US9868947B2 (en) 2015-05-04 2018-01-16 Washington University Compositions and methods for the construction of a random allelic series
WO2017058953A1 (en) 2015-09-28 2017-04-06 The Trustees Of Columbia University In The City Of New York Design and synthesis of novel disulfide linker based nucleotides as reversible terminators for dna sequencing by synthesis
WO2018165207A1 (en) 2017-03-06 2018-09-13 Singular Genomic Systems, Inc. Nucleic acid sequencing-by-synthesis (sbs) methods that combine sbs cycle steps
CA3107758A1 (en) 2018-08-10 2020-02-13 Life Technologies Corporation Silicon-substituted rhodamine dyes and dye conjugates
EP3870593A4 (en) 2018-10-25 2022-11-16 Singular Genomics Systems, Inc. Nucleotide analogues
CN113453692A (en) 2019-01-08 2021-09-28 奇异基因组学系统公司 Nucleotide cleavable linkers and uses thereof
AU2020407267A1 (en) 2019-12-18 2022-06-16 F. Hoffmann-La Roche Ag Methods of sequencing by synthesis using a consecutive labeling scheme
US20240067673A1 (en) * 2020-10-21 2024-02-29 Big Shenzhen Modified nucleoside or nucleotide
US20220145345A1 (en) 2020-11-11 2022-05-12 Microsoft Technology Licensing, Llc Spatial control of polynucleotide synthesis by strand capping

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
WO2001025247A1 (en) * 1999-10-05 2001-04-12 Quiatech Ab Compounds for protecting hydroxyls and methods for their use
WO2002029003A2 (en) * 2000-10-06 2002-04-11 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding dna and rna
WO2004018497A2 (en) * 2002-08-23 2004-03-04 Solexa Limited Modified nucleotides for polynucleotide sequencing

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
WO2001025247A1 (en) * 1999-10-05 2001-04-12 Quiatech Ab Compounds for protecting hydroxyls and methods for their use
WO2002029003A2 (en) * 2000-10-06 2002-04-11 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding dna and rna
WO2004018497A2 (en) * 2002-08-23 2004-03-04 Solexa Limited Modified nucleotides for polynucleotide sequencing

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
OHGI T ET AL: "A New RNA Synthetic Method with a 2'-O-(2-Cyanoethoxymethyl) Protecting Group", ORGANIC LETTERS, AMERICAN CHEMICAL SOCIETY, COLUMBUS, OH; US, vol. 7, no. 16, 1 January 2005 (2005-01-01), pages 3477 - 3480, XP003009345, ISSN: 1523-7060 *
SANEYOSHI H ET AL: "A General Method for the Synthesis of 2'-O-Cyanoethylated Oligoribonucleotides Having Promising Hybridization Affinity for DNA and RNA and Enhanced Nuclease Resistance", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, vol. 70, no. 25, 1 January 2005 (2005-01-01), pages 10453 - 10460, XP003017305, ISSN: 0022-3263 *
UMEMOTO T ET AL: "Oligoribonucleotide synthesis by the use of 1-(2-cyanoethoxy)ethyl (CEE) as a 2'-hydroxy protecting group", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, vol. 45, no. 52, 20 December 2004 (2004-12-20), pages 9529 - 9531, XP004727393, ISSN: 0040-4039 *

Also Published As

Publication number Publication date
WO2008037568A2 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
WO2008037568A3 (en) Reversible terminators for efficient sequencing by synthesis
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
WO2004024777A8 (en) Hydroxyalkyl starch derivatives
GB0220581D0 (en) Organic Compound
WO2007022070A3 (en) Modified fc molecules
WO2009061941A3 (en) Baseless nucleotide analogues and uses thereof
NO20091242L (en) Process for the preparation of biaryl-substituted 4-amino-butyric acid or derivatives thereof and their use in the preparation of NEP inhibitors
WO2008012733A3 (en) Method and composition for permanently shaping hair
WO2008016909A3 (en) Nucleotide analogs
TW200702330A (en) 3,4,5-Substituted piperidines
WO2008008481A3 (en) Deprotection of functional groups by multi-photon induced electron transfer
WO2007074915A8 (en) Water-soluble benzoazepine compound and its pharmaceutical composition
WO2007119001A3 (en) Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
HRP20090103T3 (en) Method for preparing 4 -amino-4'-demethyl-4-desoxypodophyllotoxin
BRPI0409471A (en) process for the preparation of unsubstituted 2-cyanopyrrolidines
DE602006000226D1 (en) Process for the preparation of Adapalene
CA2531167A1 (en) Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
WO2005000803A1 (en) Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
WO2008007153A3 (en) Antiviral compounds
WO2008117871A1 (en) Nitrogen-containing redox catalyst
WO2008139845A1 (en) Novel amide derivative
CA2641542A1 (en) Improved process for producing nitroisourea derivatives
EP1693704A3 (en) Resist composition and pattern forming method using the same
AU2002349247A1 (en) Substrate for tafi (a)
MY152869A (en) Chemical process

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07803187

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC DATED 14.07.2009

122 Ep: pct application non-entry in european phase

Ref document number: 07803187

Country of ref document: EP

Kind code of ref document: A2